wHX LABS DUBAI 2026
Visit us at booth #SA. D56 to discover our turnkey, fully automated autoimmune diagnostic solutions.
About AliveDx
At AliveDx, we empower diagnostic insights, transform patient care, and innovate for life. With 30+ years in in-vitro diagnostics, we advance global diagnostics in autoimmune, allergy, and beyond. Our Alba, MosaiQ, and LumiQ brands generate both economic and
clinical value by simplifying workflows and delivering fast, accurate results that enhance clinical decision-making. At AliveDx, we innovate for life.
MosaiQ® Solution
A fully automated high throughput platform for multiplex testing of complex conditions for Autoimmune, Allergy, and beyond. MosaiQ delivers fast actionable insights by combining advanced microarrays with an instrument engineered for ease-of-use and accuracy.
LumiQ® (IFA) Solution
The combination of MosaiQ® and LumiQ® platforms provides a unique, automated, seamlessly integrated solution to cover your needs for screening and identification of autoantibodies for a wide range of diseases.
Our Assay Menu
MosaiQ AiPlex® CD (Celiac Disease)
IVDR-CE Marked
MosaiQ AiPlex® CTDplus (Connective Tissue Disease)
IVDR-CE Marked
MosaiQ AiPlex® APS (Antiphospholipid Syndrome)
In development subject to regulatory clearance
MosaiQ AiPlex® VAS (Autoimmune vasculitis)
IVDR-CE Marked
Menus and capabilities are subject to change. Not all methods may be available in all territories subject to clearance in other territories.
Allergy Assays
AllergyPlex® COMBO
In Development subject to regulatory clearances
Discover Product Brochures
View them here:
Customer Testimonial
Established in the French medical landscape for several decades, Inovie Labosud Provence is a multi-site medical biology laboratory that plays a key role in the national healthcare system.
In the world of diagnostics, consistency and efficiency are paramount. Inovie evaluated our MosaiQ®AiPlex CTDplus solution, which provides 15 autoantibody biomarkers in a single test for connective tissue diseases.
Their assessment showed highly consistent results with their existing testing methods, including immunofluorescence techniques, confirming the advantages of multiplex microarray technology for high-throughput labs.
Facility tour videos
Take a virtual tour of our facilities below:
United Kingdom (Transfusion Business)
Switzerland (Clinical Business)
